Centro Hospitalar Lisboa Ocidental   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Lisbon Portugal (1902)

Organization Overview

First Clinical Trial
2011
NCT01408810
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Centro Hospitalar Lisboa Ocidental | Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz

Active Ingredients

Drugs in Phase 4 Trials (2)

infliximab (remicade) (1 trial)

polyethylene glycol (1 trial)

Drugs in Phase 3 Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Colitis (Phase 4)

Colitis, Ulcerative (Phase 4)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3